Stantec (STN) Tops Q4 EPS by 38c

Stantec (NYSE: STN) reported Q4 EPS of Cdn$1.25, Cdn$0.38 better than the analyst estimate of Cdn$0.87. Revenue for the quarter came in at Cdn$1.64 billion versus the consensus estimate of Cdn$1.19 billion.

For earnings history and earnings-related data on Stantec (STN) click here.

You May Also Be Interested In

• Jefferies Upgrades Deckers Outdoor (DECK) to Buy
• Morgan Stanley Downgrades Cosmos Pharmaceuticals Corp. (3349:JP) (CSMYF) to Equalweight
• Microsoft (MSFT) Reiterated at Market Outperform by Citizens as Frontier Launch Announced